Comparison

CCG-203971

Item no. MOLN-M18020-500mg
Manufacturer Molnova
CASRN 1443437-74-8
Amount 500 mg
Quantity options 100 mg 10 mg 1 g 200 mg 25 mg 500 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Purity >98% (HPLC)
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Storage Conditions
(-20°C)
Molecular Weight
408, 88
Brief description
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.
Note
Research use only, not for human use.
Stability
≥ 2 years
Receptor
others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close